Table 2.
Bayesian acceptable ranges of AUC0–24h used for dose individualization (Svensson et al., 2019).
Time after first dose (days) | AUC0–24h (h. mg/L) |
---|---|
1 | 342–408 |
7 | 217–259 |
14 | 189–224 |
28 | 182–215 |
56 | 181–214 |
AUC0–24h, area under the plasma concentration-time curve from time zero up to 24 h.